A Data Monitoring Committee (DMC) refers to an impartial and autonomous committee that a sponsor can establish to periodically evaluate the advancement of a clinical trial. The DMC assesses safety data, monitors critical efficacy endpoints, and provides recommendations to the sponsor regarding the course of action for the trial. This may involve suggesting continuation, modification, or termination of the trial based on the collected data and its analysis.
The DMC plays a crucial role in enhancing the oversight and integrity of clinical trials by ensuring rigorous scrutiny and unbiased decision-making.
Confounding by Indication
Contact our experts today
Composed of proven experts from the pharmaceutical industry, our team is ready to answer to your needs in any
area of product development, commercialisation and early access programs, and life cycle management